Riverview Trust Company’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,187
Closed -$20.7K 521
2025
Q1
$20.7K Hold
1,187
0.02% 417
2024
Q4
$20.6K Hold
1,187
0.02% 453
2024
Q3
$22.1K Hold
1,187
0.02% 426
2024
Q2
$18.3K Hold
1,187
0.02% 479
2024
Q1
$17.5K Buy
+1,187
New +$16.4K 0.01% 535
2023
Q4
Sell
-1,187
Closed -$16.5K 538
2023
Q3
$16.5K Hold
1,187
0.01% 467
2023
Q2
$14K Hold
1,187
0.01% 578
2023
Q1
$13.7K Hold
1,187
0.01% 557
2022
Q4
$15K Hold
1,187
0.01% 446
2022
Q3
$16K Hold
1,187
0.02% 418
2022
Q2
$17K Buy
+1,187
New +$15.9K 0.01% 444
2019
Q2
Sell
-180
Closed -$4K 385
2019
Q1
$4K Buy
+180
New +$3.41K ﹤0.01% 310

Other funds holding SBRA

Riverview Trust Company's SBRA Position: Q2 2025 in Review

Riverview Trust Company sold out of Sabra Healthcare REIT (SBRA) in Q2 2025, closing a stake of 1,187 shares — an estimated $20.7K sold.

Riverview Trust Company first reported a position in SBRA in Q1 2019 and held it in 12 quarters. The position peaked at $22.1K in Q3 2024. 396 funds tracked by Wall St. Rank hold SBRA as of Q2 2025.

  • Riverview Trust Company reported no remaining Sabra Healthcare REIT position as of Q2 2025 after selling out during the quarter.
  • Riverview Trust Company sold 1,187 Sabra Healthcare REIT shares in Q2 2025, an estimated $20.7K.
  • Riverview Trust Company first reported a position in Sabra Healthcare REIT in Q1 2019 and held it in 12 quarters.
  • Riverview Trust Company's Sabra Healthcare REIT position peaked at $22.1K in Q3 2024.
  • 396 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2025.

Based on Riverview Trust Company's 13F filing for Q2 2025, filed 21 Jul 2025.